IN
Inhibrx Biosciences
INBX·NASDAQLa Jolla CAFounded 2016100 employees
Small CapbiotechPublicRare DiseaseOncology
Platform: Multi-spec Ab
Market Cap
$1B
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (INBX)
Loading INBX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Elrazasiran | INB-4131 | NDA/BLA | 2 | EZH2 | Dravet | ||
| INB-9118 | INB-9118 | Phase 3 | 3 | Aβ | Parkinson's |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)